Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the I-f inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure